Abstract |
Current tuberculosis (TB) vaccine strategies are largely aimed at activating conventional T cell responses to mycobacterial protein antigens. However, the lipid-rich cell wall of Mycobacterium tuberculosis (M. tuberculosis) is essential for pathogenicity and provides targets for unconventional T cell recognition. Group 1 CD1-restricted T cells recognize mycobacterial lipids, but their function in human TB is unclear and their ability to establish memory is unknown. Here, we characterized T cells specific for mycolic acid (MA), the predominant mycobacterial cell wall lipid and key virulence factor, in patients with active TB infection. MA-specific T cells were predominant in TB patients at diagnosis, but were absent in uninfected bacillus Calmette-Guérin-vaccinated (BCG-vaccinated) controls. These T cells were CD1b restricted, detectable in blood and disease sites, produced both IFN-γ and IL-2, and exhibited effector and central memory phenotypes. MA-specific responses contracted markedly with declining pathogen burden and, in patients followed longitudinally, exhibited recall expansion upon antigen reencounter in vitro long after successful treatment, indicative of lipid-specific immunological memory. T cell recognition of MA is therefore a significant component of the acute adaptive and memory immune response in TB, suggesting that mycobacterial lipids may be promising targets for improved TB vaccines.
|
Authors | Damien J Montamat-Sicotte, Kerry A Millington, Carrie R Willcox, Suzie Hingley-Wilson, Sarah Hackforth, John Innes, Onn Min Kon, David A Lammas, David E Minnikin, Gurdyal S Besra, Benjamin E Willcox, Ajit Lalvani |
Journal | The Journal of clinical investigation
(J Clin Invest)
Vol. 121
Issue 6
Pg. 2493-503
(Jun 2011)
ISSN: 1558-8238 [Electronic] United States |
PMID | 21576820
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antigens, Bacterial
- Antigens, CD1
- Antitubercular Agents
- BCG Vaccine
- Interleukin-2
- Mycolic Acids
- Tuberculosis Vaccines
- Interferon-gamma
|
Topics |
- Acute Disease
- Adaptive Immunity
- Adult
- Aged
- Antigens, Bacterial
(immunology)
- Antigens, CD1
(immunology)
- Antitubercular Agents
(therapeutic use)
- BCG Vaccine
(immunology)
- Cell Wall
(immunology)
- Cells, Cultured
(immunology)
- Female
- Humans
- Immunologic Memory
(immunology)
- Interferon-gamma
(metabolism)
- Interleukin-2
(metabolism)
- Male
- Middle Aged
- Mycobacterium tuberculosis
(immunology, pathogenicity)
- Mycolic Acids
(immunology)
- T-Cell Antigen Receptor Specificity
- T-Lymphocyte Subsets
(immunology, metabolism)
- Tuberculosis
(drug therapy, immunology, prevention & control)
- Tuberculosis Vaccines
- Virulence
- Young Adult
|